Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Loss of One or Two PATZ1 Alleles Has a Critical Role in the Progression of Thyroid Carcinomas Induced by the RET/PTC1 Oncogene.

Monaco M, Palma G, Vitiello M, Capiluongo A, D'Andrea B, Vuttariello E, Luciano A, Cerchia L, Chiappetta G, Arra C, Fusco A, Fedele M.

Cancers (Basel). 2018 Mar 27;10(4). pii: E92. doi: 10.3390/cancers10040092.

2.

Dissecting the Potential Roles of Nigella sativa and Its Constituent Thymoquinone on the Prevention and on the Progression of Alzheimer's Disease.

Cascella M, Bimonte S, Barbieri A, Del Vecchio V, Muzio MR, Vitale A, Benincasa G, Ferriello AB, Azzariti A, Arra C, Cuomo A.

Front Aging Neurosci. 2018 Feb 9;10:16. doi: 10.3389/fnagi.2018.00016. eCollection 2018. Review.

3.

Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS Production.

Riccio G, Antonucci S, Coppola C, D'Avino C, Piscopo G, Fiore D, Maurea C, Russo M, Rea D, Arra C, Condorelli G, Di Lisa F, Tocchetti CG, De Lorenzo C, Maurea N.

Front Physiol. 2018 Feb 6;9:38. doi: 10.3389/fphys.2018.00038. eCollection 2018.

4.

Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting.

Petrizzo A, Mauriello A, Luciano A, Rea D, Barbieri A, Arra C, Maiolino P, Tornesello M, Gigantino V, Botti G, Ciliberto G, Buonaguro FM, Tagliamonte M, Buonaguro L.

Oncotarget. 2017 Dec 8;9(3):3576-3589. doi: 10.18632/oncotarget.23181. eCollection 2018 Jan 9.

5.

The effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA.MB231 cells.

Bimonte S, Barbieri A, Cascella M, Rea D, Palma G, Del Vecchio V, Forte CA, Del Prato F, Arra C, Cuomo A.

Onco Targets Ther. 2018 Jan 3;11:185-191. doi: 10.2147/OTT.S145780. eCollection 2018.

6.

Dissecting the mechanisms and molecules underlying the potential carcinogenicity of red and processed meat in colorectal cancer (CRC): an overview on the current state of knowledge.

Cascella M, Bimonte S, Barbieri A, Del Vecchio V, Caliendo D, Schiavone V, Fusco R, Granata V, Arra C, Cuomo A.

Infect Agent Cancer. 2018 Jan 15;13:3. doi: 10.1186/s13027-018-0174-9. eCollection 2018. Review.

7.

Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs.

Coppola C, Rienzo A, Piscopo G, Barbieri A, Arra C, Maurea N.

Cancer Treat Rev. 2018 Feb;63:135-143. doi: 10.1016/j.ctrv.2017.11.009. Epub 2017 Dec 6. Review.

8.

HMGA2 cooperates with either p27kip1 deficiency or Cdk4R24C mutation in pituitary tumorigenesis.

Fedele M, Paciello O, De Biase D, Monaco M, Chiappetta G, Vitiello M, Barbieri A, Rea D, Luciano A, Papparella S, Arra C, Fusco A.

Cell Cycle. 2018;17(5):580-588. doi: 10.1080/15384101.2017.1403682. Epub 2018 Jan 30.

PMID:
29157111
9.

The HMGA1 Pseudogene 7 Induces miR-483 and miR-675 Upregulation by Activating Egr1 through a ceRNA Mechanism.

De Martino M, Palma G, Azzariti A, Arra C, Fusco A, Esposito F.

Genes (Basel). 2017 Nov 17;8(11). pii: E330. doi: 10.3390/genes8110330.

10.

PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.

Guadagno E, Vitiello M, Francesca P, Calì G, Caponnetto F, Cesselli D, Camorani S, Borrelli G, Califano M, Cappabianca P, Arra C, Crescenzi E, Cerchia L, De Caro MLDB, Fedele M.

Oncotarget. 2017 Jul 25;8(35):59282-59300. doi: 10.18632/oncotarget.19546. eCollection 2017 Aug 29.

11.

Enhanced Drug Delivery into Cell Cytosol via Glycoprotein H-Derived Peptide Conjugated Nanoemulsions.

Fotticchia T, Vecchione R, Scognamiglio PL, Guarnieri D, Calcagno V, Di Natale C, Attanasio C, De Gregorio M, Di Cicco C, Quagliariello V, Maurea N, Barbieri A, Arra C, Raiola L, Iaffaioli RV, Netti PA.

ACS Nano. 2017 Oct 24;11(10):9802-9813. doi: 10.1021/acsnano.7b03058. Epub 2017 Aug 28.

PMID:
28820568
12.

Role of Nigella sativa and Its Constituent Thymoquinone on Chemotherapy-Induced Nephrotoxicity: Evidences from Experimental Animal Studies.

Cascella M, Palma G, Barbieri A, Bimonte S, Amruthraj NJ, Muzio MR, Del Vecchio V, Rea D, Falco M, Luciano A, Arra C, Cuomo A.

Nutrients. 2017 Jun 17;9(6). pii: E625. doi: 10.3390/nu9060625. Review.

13.

A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors.

Santagata S, Portella L, Napolitano M, Greco A, D'Alterio C, Barone MV, Luciano A, Gramanzini M, Auletta L, Arra C, Zannetti A, Scala S.

Sci Rep. 2017 May 31;7(1):2554. doi: 10.1038/s41598-017-02818-6.

14.

d-Aspartic acid ameliorates painful and neuropsychiatric changes and reduces β-amyloid Aβ1-42 peptide in a long lasting model of neuropathic pain.

D'Aniello A, Luongo L, Romano R, Iannotta M, Marabese I, Boccella S, Belardo C, de Novellis V, Arra C, Barbieri A, D'Aniello B, Scandurra A, Magliozzi L, Fisher G, Guida F, Maione S.

Neurosci Lett. 2017 Jun 9;651:151-158. doi: 10.1016/j.neulet.2017.04.041. Epub 2017 May 6.

PMID:
28487079
15.

Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier.

Monaco I, Camorani S, Colecchia D, Locatelli E, Calandro P, Oudin A, Niclou S, Arra C, Chiariello M, Cerchia L, Comes Franchini M.

J Med Chem. 2017 May 25;60(10):4510-4516. doi: 10.1021/acs.jmedchem.7b00527. Epub 2017 May 10.

PMID:
28471660
16.

Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.

Carriero MV, Bifulco K, Ingangi V, Costantini S, Botti G, Ragone C, Minopoli M, Motti ML, Rea D, Scognamiglio G, Botti G, Arra C, Ciliberto G, Pessi A.

Sci Rep. 2017 May 2;7(1):1312. doi: 10.1038/s41598-017-01425-9.

17.

POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with the human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation.

Pero R, Palmieri D, Angrisano T, Valentino T, Federico A, Franco R, Lembo F, Klein-Szanto AJ, Del Vecchio L, Montanaro D, Keller S, Arra C, Papadopoulou V, Wagner SD, Croce CM, Fusco A, Chiariotti L, Fedele M.

J Biol Chem. 2017 Mar 31;292(13):5609. doi: 10.1074/jbc.A117.346270. No abstract available.

18.

Synthesis and Antitumor Activity of New Group 3 Metallocene Complexes.

Caporale A, Palma G, Mariconda A, Del Vecchio V, Iacopetta D, Parisi OI, Sinicropi MS, Puoci F, Arra C, Longo P, Saturnino C.

Molecules. 2017 Mar 28;22(4). pii: E526. doi: 10.3390/molecules22040526.

19.

Critical role of HMGA proteins in cancer cell chemoresistance.

D'Angelo D, Mussnich P, Arra C, Battista S, Fusco A.

J Mol Med (Berl). 2017 Apr;95(4):353-360. doi: 10.1007/s00109-017-1520-x. Epub 2017 Mar 14. Review.

PMID:
28293697
20.

Anticancer and Anti-Inflammatory Properties of Ganoderma lucidum Extract Effects on Melanoma and Triple-Negative Breast Cancer Treatment.

Barbieri A, Quagliariello V, Del Vecchio V, Falco M, Luciano A, Amruthraj NJ, Nasti G, Ottaiano A, Berretta M, Iaffaioli RV, Arra C.

Nutrients. 2017 Feb 28;9(3). pii: E210. doi: 10.3390/nu9030210.

21.

miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene.

Forzati F, De Martino M, Esposito F, Sepe R, Pellecchia S, Malapelle U, Pellino G, Arra C, Fusco A.

BMC Cancer. 2017 Mar 4;17(1):170. doi: 10.1186/s12885-017-3158-z.

22.

Tumour biomarkers: homeostasis as a novel prognostic indicator.

Falco M, Palma G, Rea D, De Biase D, Scala S, D'Aiuto M, Facchini G, Perdonà S, Barbieri A, Arra C.

Open Biol. 2016 Dec;6(12). pii: 160254. Review.

23.

HMGA1P7-pseudogene regulates H19 and Igf2 expression by a competitive endogenous RNA mechanism.

De Martino M, Forzati F, Marfella M, Pellecchia S, Arra C, Terracciano L, Fusco A, Esposito F.

Sci Rep. 2016 Nov 22;6:37622. doi: 10.1038/srep37622.

24.

Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking.

Coppola C, Riccio G, Barbieri A, Monti MG, Piscopo G, Rea D, Arra C, Maurea C, De Lorenzo C, Maurea N.

Onco Targets Ther. 2016 Nov 2;9:6785-6794. eCollection 2016.

25.

New Adamantyl Chalcones: Synthesis, Antimicrobial and Anticancer Activities.

Tabbi A, Tebbani D, Caporale A, Saturnino C, Nabavi SF, Giuseppe P, Arra C, Canturk Z, Turan-Zitouni G, Merazig H, Sobarzo-Sanchez E, Rastrelli L.

Curr Top Med Chem. 2017;17(4):498-506.

PMID:
27558673
26.

PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas.

Franco R, Scognamiglio G, Valentino E, Vitiello M, Luciano A, Palma G, Arra C, La Mantia E, Panico L, Tenneriello V, Pinto A, Frigeri F, Capobianco G, Botti G, Cerchia L, De Chiara A, Fedele M.

Oncotarget. 2016 Sep 13;7(37):59158-59172. doi: 10.18632/oncotarget.10993.

27.

The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells.

Ingangi V, Bifulco K, Yousif AM, Ragone C, Motti ML, Rea D, Minopoli M, Botti G, Scognamiglio G, Fazioli F, Gallo M, De Chiara A, Arra C, Grieco P, Carriero MV.

Oncotarget. 2016 Aug 23;7(34):54474-54487. doi: 10.18632/oncotarget.9976.

28.

Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX.

Rea D, Del Vecchio V, Palma G, Barbieri A, Falco M, Luciano A, De Biase D, Perdonà S, Facchini G, Arra C.

Biomed Res Int. 2016;2016:9750795. doi: 10.1155/2016/9750795. Epub 2016 May 18. Review.

29.

PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells.

Vitiello M, Valentino T, De Menna M, Crescenzi E, Francesca P, Rea D, Arra C, Fusco A, De Vita G, Cerchia L, Fedele M.

Sci Rep. 2016 Apr 29;6:25268. doi: 10.1038/srep25268.

30.

Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research.

Rea D, Coppola C, Barbieri A, Monti MG, Misso G, Palma G, Bimonte S, Zarone MR, Luciano A, Liccardo D, Maiolino P, Cittadini A, Ciliberto G, Arra C, Maurea N.

In Vivo. 2016 May-Jun;30(3):279-90.

PMID:
27107087
31.

CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis.

Ieranò C, Portella L, Lusa S, Salzano G, D'Alterio C, Napolitano M, Buoncervello M, Macchia D, Spada M, Barbieri A, Luciano A, Barone MV, Gabriele L, Caraglia M, Arra C, De Rosa G, Scala S.

Nanoscale. 2016 Apr 14;8(14):7562-71. doi: 10.1039/c5nr06335c.

PMID:
26983756
32.

A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice.

Tagliamonte M, Petrizzo A, Napolitano M, Luciano A, Rea D, Barbieri A, Arra C, Maiolino P, Tornesello M, Ciliberto G, Buonaguro FM, Buonaguro L.

J Transl Med. 2016 Feb 24;14:58. doi: 10.1186/s12967-016-0812-1.

33.

HMGA1-pseudogenes and cancer.

De Martino M, Forzati F, Arra C, Fusco A, Esposito F.

Oncotarget. 2016 May 10;7(19):28724-35. doi: 10.18632/oncotarget.7427. Review.

34.

BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages.

Rosati A, Basile A, D'Auria R, d'Avenia M, De Marco M, Falco A, Festa M, Guerriero L, Iorio V, Parente R, Pascale M, Marzullo L, Franco R, Arra C, Barbieri A, Rea D, Menichini G, Hahne M, Bijlsma M, Barcaroli D, Sala G, di Mola FF, di Sebastiano P, Todoric J, Antonucci L, Corvest V, Jawhari A, Firpo MA, Tuveson DA, Capunzo M, Karin M, De Laurenzi V, Turco MC.

Nat Commun. 2015 Nov 2;6:8695. doi: 10.1038/ncomms9695.

35.

Triple negative breast cancer: looking for the missing link between biology and treatments.

Palma G, Frasci G, Chirico A, Esposito E, Siani C, Saturnino C, Arra C, Ciliberto G, Giordano A, D'Aiuto M.

Oncotarget. 2015 Sep 29;6(29):26560-74. doi: 10.18632/oncotarget.5306. Review.

36.

Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice.

Fiume G, Scialdone A, Albano F, Rossi A, Tuccillo FM, Rea D, Palmieri C, Caiazzo E, Cicala C, Bellevicine C, Falcone C, Vecchio E, Pisano A, Ceglia S, Mimmi S, Iaccino E, de Laurentiis A, Pontoriero M, Agosti V, Troncone G, Mignogna C, Palma G, Arra C, Mallardo M, Buonaguro FM, Scala G, Quinto I.

Sci Rep. 2015 Sep 7;5:13864. doi: 10.1038/srep13864.

37.

Inhibitory effect of (-)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growth.

Bimonte S, Leongito M, Barbieri A, Del Vecchio V, Barbieri M, Albino V, Piccirillo M, Amore A, Di Giacomo R, Nasto A, Granata V, Petrillo A, Arra C, Izzo F.

Infect Agent Cancer. 2015 Jul 29;10:22. doi: 10.1186/s13027-015-0016-y. eCollection 2015.

38.

Polycomb protein family member CBX7 plays a critical role in cancer progression.

Pallante P, Forzati F, Federico A, Arra C, Fusco A.

Am J Cancer Res. 2015 Apr 15;5(5):1594-601. eCollection 2015. Review.

39.

Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer Progression.

Bimonte S, Barbieri A, Rea D, Palma G, Luciano A, Cuomo A, Arra C, Izzo F.

Biomed Res Int. 2015;2015:161508. doi: 10.1155/2015/161508. Epub 2015 May 3.

40.

The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo.

Barbieri A, Bimonte S, Palma G, Luciano A, Rea D, Giudice A, Scognamiglio G, La Mantia E, Franco R, Perdonà S, De Cobelli O, Ferro M, Zappavigna S, Stiuso P, Caraglia M, Arra C.

Int J Oncol. 2015 Aug;47(2):527-34. doi: 10.3892/ijo.2015.3038. Epub 2015 Jun 8.

PMID:
26058426
41.

Ccdc6 knock-in mice develop thyroid hyperplasia associated to an enhanced CREB1 activity.

Leone V, Langella C, Esposito F, Arra C, Palma G, Rea D, Paciello O, Merolla F, De Biase D, Papparella S, Celetti A, Fusco A.

Oncotarget. 2015 Jun 20;6(17):15628-38.

42.

Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model.

Tagliamonte M, Petrizzo A, Napolitano M, Luciano A, Arra C, Maiolino P, Izzo F, Tornesello ML, Aurisicchio L, Ciliberto G, Buonaguro FM, Buonaguro L.

Cancer Immunol Immunother. 2015 Oct;64(10):1305-14. doi: 10.1007/s00262-015-1698-0. Epub 2015 May 6.

PMID:
25944003
43.

Dissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancer.

Bimonte S, Barbieri A, Palma G, Rea D, Luciano A, D'Aiuto M, Arra C, Izzo F.

Biomed Res Int. 2015;2015:878134. doi: 10.1155/2015/878134. Epub 2015 Mar 23.

44.

An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma.

Bimonte S, Barbieri A, Palaia R, Leongito M, Albino V, Piccirillo M, Arra C, Izzo F.

Infect Agent Cancer. 2015 Mar 9;10:9. doi: 10.1186/s13027-015-0004-2. eCollection 2015.

45.

PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration.

Chiappetta G, Valentino T, Vitiello M, Pasquinelli R, Monaco M, Palma G, Sepe R, Luciano A, Pallante P, Palmieri D, Aiello C, Rea D, Losito SN, Arra C, Fusco A, Fedele M.

Oncotarget. 2015 Mar 10;6(7):5310-23.

46.

Immunization with DISC1 protein in an animal model of ADHD influences behavior and excitatory amino acids in prefrontal cortex and striatum.

Ruocco LA, Treno C, Gironi Carnevale UA, Arra C, Boatto G, Pagano C, Tino A, Nieddu M, Michel M, Prikulis I, Carboni E, de Souza Silva MA, Huston JP, Sadile AG, Korth C.

Amino Acids. 2015 Mar;47(3):637-50. doi: 10.1007/s00726-014-1897-6. Epub 2015 Jan 17.

PMID:
25595600
47.

The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias.

Leone V, Ferraro A, Schepis F, Federico A, Sepe R, Arra C, Langella C, Palma G, De Lorenzo C, Troncone G, Masciullo V, Scambia G, Fusco A, Pallante P.

Cancer Lett. 2015 Feb 28;357(2):535-41. doi: 10.1016/j.canlet.2014.12.010. Epub 2014 Dec 9.

PMID:
25497869
48.

HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs.

Esposito F, De Martino M, Petti MG, Forzati F, Tornincasa M, Federico A, Arra C, Pierantoni GM, Fusco A.

Oncotarget. 2014 Sep 30;5(18):8341-54.

49.

CBX7 gene expression plays a negative role in adipocyte cell growth and differentiation.

Forzati F, Federico A, Pallante P, Colamaio M, Esposito F, Sepe R, Gargiulo S, Luciano A, Arra C, Palma G, Bon G, Bucher S, Falcioni R, Brunetti A, Battista S, Fedele M, Fusco A.

Biol Open. 2014 Sep 4;3(9):871-9. doi: 10.1242/bio.20147872.

50.

The anti-apoptotic BAG3 protein is expressed in lung carcinomas and regulates small cell lung carcinoma (SCLC) tumor growth.

Chiappetta G, Basile A, Barbieri A, Falco A, Rosati A, Festa M, Pasquinelli R, Califano D, Palma G, Costanzo R, Barcaroli D, Capunzo M, Franco R, Rocco G, Pascale M, Turco MC, De Laurenzi V, Arra C.

Oncotarget. 2014 Aug 30;5(16):6846-53.

Supplemental Content

Support Center